SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-109589
Filing Date
2014-03-21
Accepted
2014-03-21 10:48:07
Documents
4
Group Members
ABRAHAM LUDOMIRSKIJEFFREY DYKANSCP VITALIFE II ASSOCIATES, L.P.SCP VITALIFE II GP, LTDSCP VITALIFE PARTNERS (ISRAEL) II, L. P.WAYNE B. WEISMANWINSTON J. CHURCHILL

Document Format Files

Seq Description Document Type Size
1 SC 13D d697132dsc13d.htm SC 13D 135200
2 EXHIBIT 1 d697132dex991.htm EX-99.1 110235
3 EXHIBIT 2 d697132dex992.htm EX-99.2 16584
4 EXHIBIT 3 d697132dex993.htm EX-99.3 8119
  Complete submission text file 0001193125-14-109589.txt   271813
Mailing Address C/O SCP PARTNERS 1200 LIBERTY RIDGE WAY STE 300 WAYNE PA 19087
Business Address C/O SCP PARTNERS 1200 LIBERTY RIDGE WAY STE 300 WAYNE PA 19087
SCP Vitalife Partners II LP (Filed by) CIK: 0001398330 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Subject) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88042 | Film No.: 14708920
SIC: 2834 Pharmaceutical Preparations